Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.

Summary

This is a prospective, single-center, single-arm Phase II study evaluating the efficacy of the myDIET software tool in the nutritional management of patients with localized and resectable esogastric junction cancer.

Eligibility

Inclusion Criteria:

* Patient 18 years of age or older at date of signing informed consent to participate;
* Histologically proven diagnosis of gastric adenocarcinoma or OGJ;
* Localized, resectable disease;
* Patient treated with perioperative Oxaliplatin-based chemotherapy,
* Performance status (ECOG): 0-2;
* Membership of a social security scheme;
* Signed informed consent to participate.

Exclusion Criteria:

* Other associated solid cancer or haemopathy;
* Presence of severe comorbidity (Charlson index \< 9)
* Presence of unbalanced dysthyroidism (TSH not within laboratory norm at inclusion, usually between 0.4 and 4 mUI/L);
* History of gastric, duodenal or esophageal surgery;
* Inability to comply with study requirements, including :

  * Impossibility for the patient or his/her caregiver to connect to myDIET;
  * Difficulty in understanding the written French language;
  * Psychological incapacity (e.g. excessive vulnerability, psychiatric disorder) or physical incapacity (e.g.

physical/motor disability);

* Patient under guardianship, curatorship or safeguard of justice;
* Patients already participating in a clinical trial or interventional study likely to interfere with the evaluation of the primary endpoint.

Conditions3

Browse More Trials